Other
Stroke in children
Bettina Henzi, Maja Steinlin ·
Summary
Written by AI, not yet AICS's view · claude-sonnet-5-5This document is a short overview of stroke in children, a rare but serious condition with lifelong effects on patients and families. It says diagnosis is often delayed because awareness is low, symptoms are specific to children, many other conditions look like stroke, and emergency brain imaging is hard to access. It notes that the causes of childhood stroke differ from those in adults. It also says treatment guidelines are mostly borrowed from adult guidelines and expert opinion, and calls for more research.
Key points
- Childhood stroke is rare but has lifelong consequences for patients and families.
- It is increasingly recognised as a socioeconomic burden lasting many years after the acute event.
- Diagnosis is significantly delayed because of low awareness, child-specific symptoms, stroke mimics and limited access to emergency neuroimaging.
- Cerebral vasculopathies are the leading cause of childhood arterial ischaemic stroke, followed by cardioembolic causes.
- Treatment guidelines are largely based on adult guidelines and expert consensus.
Limitations
Only a short abstract is available, with no data, methods or country focus, so it gives no figures on how common childhood stroke is or on outcomes. It does not say anything about children in Africa or any other specific setting.
Abstract
Stroke in children is a rare, but terrifying disease and its lifelong sequelae weigh heavy on patients and families. It is also increasingly recognized as a socioeconomic burden, ongoing for many years after the acute manifestation. There is a significant delay in diagnosis of childhood stroke. This is caused by several factors: lack of awareness among the public and professionals, childhood-specific manifestations, numerous stroke mimics, and last but not least, limited access to emergency neuroimaging for children. Fast stroke recognition tools need adaption to the special needs in children. Childhood arterial ischaemic stroke differs in aetiology from adult stroke with cerebral vasculopathies being the leading cause and cardioembolic aetiology ranking second. However, treatment guidelines are largely based on adult guidelines and expert consensus. Future research has to put emphasis on understanding pathophysiology, defining specific treatment options, and providing evidence for treatment guidelines in paediatric stroke.